Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - Pleiocarpa_mutica bark alkaloid extract

ABSTRACT: LC-MS/MS analysis related to Pleiocarpa mutica bark alkaloid extract.

INSTRUMENT(S): Agilent Qtof 6530

ORGANISM(S): Pleiocarpa Mutica (ncbitaxon:141602)

SUBMITTER: Mehdi Beniddir

PROVIDER: MSV000095596 | GNPS | Wed Aug 14 03:20:00 BST 2024

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS - Voacanga_africana bark alkaloid extract

Project description:LC-MS/MS analysis of the bark alkaloid extract of Voacanga africana

2024-08-14 | MSV000095597 | GNPS

GNPS - Mostuea_brunonis stem alkaloid extract

Project description:Mostuea_brunonis (Gabon) stem alkaloid extract stems

2020-04-02 | MSV000085221 | GNPS

Medicinal Food Homology in Action: Flos Sophorae Immaturus-Broccoli Seed Extract Suppresses Tumor Growth through G2/M Arrest and EMT Inhibition

Project description:Despite advancements in cancer therapy, metastasis and chemoresistance remain critical challenges due to tumor heterogeneity and compensatory pathways. This study investigates the synergistic anti-tumor potential of Flos Sophorae Immaturus (FSI) and broccoli seed extract (BSE), two natural products aligned with the "medicinal food homology" paradigm. Using in vitro and in vivo models of lung and prostate cancers, we demonstrate that FSI-BSE (F/B extract) co-treatment exerts supra-additive effects by concurrently inducing G2/M cell cycle arrest and suppressing epithelial-mesenchymal transition (EMT). Mechanistically, with integrative LC-MS/MS, network pharmacology, molecular docking, transcriptomic profiling, and molecular experimental validation, this study revealed that F/B extract targets and disrupts the cell cycle regulators such as cyclin-dependent kinases (CDKs) and cell division cycle 25 (CDC25), as well as the EMT effectors (e.g., Matrix metalloproteinase, Snail, and E-cadherin). Additionally, F/B extract suppressed tumor growth without toxicity in xenograft mouse models, supported by unaltered organ histology and blood parameters. These findings demonstrate a polypharmacological strategy leveraging dietary botanicals to address cancer complexity. By bridging cell cycle arrest and EMT inhibition, F/B extract treatment offers a non-toxic adjuvant approach with translational potential, underscoring the therapeutic value of medicinal food homology in oncology.

2025-09-01 | GSE305654 | GEO

Independent evolution of ipecac alkaloid biosynthesis

Project description:ipecac alkaloid biosynthesis

| PRJEB80476 | ENA

Project description:LC-MS/MS(Lipid metabolomics)

| PRJNA1297903 | ENA

Regulation of alkaloid biosynthesis by miRNAs in opium poppy

2014-12-15 | GSE62716 | GEO

Polyomic analyses of dopaminergic neurons isolated from human substantia nigra in Parkinson’s disease: An exploratory study.

Project description:In this exploratory study, we used laser microdissection to extract dopaminergic neurons from 10 human SNpc samples obtained at autopsy in Parkinson’s disease patients and control subjects. Extracted RNA and proteins were identified by RNA sequencing and nano-LC-MS/MS, respectively, and the differential expression between Parkinson’s disease and control group was assessed.

2021-06-30 | GSE169755 | GEO

Regulation of alkaloid biosynthesis by miRNAs in opium poppy

Project description:MicroRNAs (miRNA) are ~21 nucleotide long, small endogenous non-coding RNAs that functioning in regulation of gene expression found in many eukaryotes. In this study, small RNA libraries of opium poppy from four different tissues (leaf, root, capsule, stem) were sequenced using high-throughput next generation Illumina sequencing (Solexa) technology to investigate potential mode of actions of miRNAs in alkaloid biosynthesis. A total of 27 opium poppy miRNAs which have roles in regulation of alkaloid biosynthesis were identified in this study. A six chip study using miRNA isolated from four separate tissues (capsule, leaf, stem, root). small RNA libraries of opium poppy tissues were sequenced using high-throughput next generation Illumina sequencing (Solexa) technology to investigate potential mode of actions of miRNAs in alkaloid biosynthesis. Furthermore, the novel opium poppy miRNAs were also confirmed by a direct small RNA cloning strategy. The microarray platform were performed to measure and analyze the mirnome of the different opium poppy tissues.

2014-12-15 | E-GEOD-62716 | biostudies-arrayexpress

Proteomics_LC-MS_MS

Project description:Proteomics LC-MS MS dataset

| EGAD00010001006 | EGA

An Investigation of the Anticancer Mechanism of Caesalpinia sappan L. Extract Against Colorectal Cancer by Integrating a Network Pharmacological Analysis and Experimental Validation

Project description:Caesalpinia sappan L. has exhibited various pharmacological effects, yet its anticancer activities against colorectal cancer (CRC) and underlying molecular mechanisms remain unclear. This study investigated the anticancer properties of an ethanol extract of C. sappan L. (CSE) against CRC cells, focusing on the identification of bioactive compounds and their mechanisms of action. A network pharmacology analysis was conducted to identify potential CRC targets and bioactive compounds of CSE, using LC-MS for compound identification. The anticancer effects of CSE were then validated through in vitro and in vivo models of CRC. The network pharmacological approach identified 87 overlapping genes between CSE targets and CRC-related genes, with protein–protein interaction analysis highlighting 33 key target genes. CSE inhibited cell proliferation in human CRC cell lines, including HCT 116, KM12SM, HT-29, and COLO 205, and induced apoptosis via caspase 3/7 activation. Western blot analyses confirmed the modulation of critical signaling pathways, including STAT3, AKT, and mitogen-activated protein kinases. Furthermore, CSE significantly suppressed tumor growth in MC38 CRC-bearing mice. These findings suggest that CSE possesses substantial potential as a natural anticancer agent for CRC treatment, highlighting the need for further exploration in therapeutic development.

2025-12-09 | GSE313097 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data